USP India

On #WorldStandardsDay, we proudly join ISO - International Organization for Standardization, ANSI - American National Standards Institute, and many others to celebrate our shared vision for a better world, made possible through public quality standards. Today and every day, we are grateful for—USP Expert Volunteers—the global network of independent scientists who are at the heart of US Pharmacopeia's standards development, review, and revision process. From all of us at USP, we say thank you to each #USPExpertVolunteer for the commitment, scientific rigor, and passion that advance our quality standards and global #PublicHealth. And we invite you to join us and help advance quality-assured medical products, equitable and accessible care, pharmaceutical innovation, supply chain resilience, and a healthier, safer world for all. Apply to volunteer with USP in 2025-2030: Bit.ly/USPExpertVolunteer #ProudToBeUSP #Standards4SDGs

Join us for a one-day workshop on Analytical Method Validation, Verification, and Transfer! 📅 Date: Friday, 18th October 📍 Venue: Hyatt Centric, Dehradun ⏰ Time: 9:30 AM - 4:30 PM IST US Pharmacopeia India, in collaboration with the Food Safety and Drug Administration, Uttarakhand, is excited to host this insightful workshop with support from Chromachemie Laboratory Private Limited. This event is a unique opportunity for pharma professionals to engage with industry leaders and experts on topics crucial to drug quality. 💡 Key Workshop Highlights: Overview of USP USP General Chapters: <621> Chromatography, <1225> Validation of Compendial Procedures, and <1224> Transfer of Analytical Procedures, Importance of primary standards and the new prednisone tablet (DPVS) and Panel discussion on ‘The Role of Standards in Driving Medicine Quality’ Whether you're working in Quality Control, Assurance, R&D, Regulatory Affairs, or Manufacturing, this workshop is designed to provide actionable insights. For registrations support, group nominations, please reach out to: Koustavayan.Chowdhury@USP.org, Ms. Mala, mala@chromachemie.co.in / Mr.Umesh, umesh@chromachemie.co.in

The countdown has begun for the 19th International Conference of Drug Regulatory Authorities (ICDRA), 2024 happening in Delhi, and we’re thrilled that US Pharmacopeia India is here in full force! 📍 Visit our Stall (91,104) to meet our team of experts and discover how U.S. Pharmacopeia is collaborating with regulators across the globe to strengthen medicine quality and safety. Learn how we’re supporting the pharma industry with world-class standards and innovative solutions to help protect public health. 🗓️ Event Dates: 14th-15th'Oct We can't wait to connect with you and discuss ways we can work together to ensure a healthier future for everyone. 💊✨ #ICDRA2024 #USPIndia #PharmaExcellence #MedicineQuality #GlobalRegulation

Don’t miss this chance to make a global impact! Join the #USPExpertVolunteer network for the 2025-2030 cycle. Apply today and bring your passion, commitment, and scientific rigor to a USP Expert Committee as a Member or Chair: Bit.ly/USPExpertVolunteer

As we continue the conversation around the importance of quality medicine for patient safety, we’re glad to feature Sudarshan Jain, General Secretary of the Indian Pharmaceutical Alliance sharing his perspective on the power of collaboration in safeguarding patient health, how #scheduleM has been pivotal in guiding the Indian pharmaceutical industry's commitment to providing quality medicines for patients worldwide.  Watch the video to learn more about how collaboration and adherence to quality standards are transforming patient safety in the global healthcare landscape.

India’s pharma sector continues to play a pivotal role in ensuring access to safe, high-quality medicines worldwide. Collaboration remains key in strengthening the global supply chain and maintaining patient safety at the forefront. Dr.Antony Raj Gomes shares valuable insights on how the evolving regulatory landscape has shaped the industry’s growth and continuing its adherence to global quality standards. Watch the video to learn more about the importance of quality, regulatory alignment, and collaboration in shaping the future of healthcare.

We are thrilled to announce the signing of a Letter of Intent and the proposal for a Memorandum of Understanding (MoU) between Biotechnology Industry Research Assistance Council (BIRAC) and US Pharmacopeia(USP). This collaboration marks a significant step forward in building capabilities for biomanufacturing startups in India. Together, we aim to foster cooperative activities that will enhance the quality of biopharmaceuticals and drive innovation in India's biomanufacturing sector. Stay tuned for more updates as we work together to shape the future of biomanufacturing !

Insights from the Panel Discussion on Building Regulatory Capabilities for Bio Startups in India, powered by US Pharmacopeia at #GlobalBioIndia2024! The session focused on addressing the gaps in India’s regulatory framework and the critical role incubation centers play in bridging these gaps. Through collaborations, we are paving the way for bio startups to better navigate the regulatory landscape, ensuring they have the support needed to bring innovations to market. !

As we continue our mission to prioritize patient safety, Girish Kapur, Senior Vice President, USP India Site Operations, shares insight into the challenges faced by the Indian pharmaceutical industry in maintaining the highest quality standards amidst growing global demand. 📹 Watch the insight and learn more about US Pharmacopeia’s unwavering support for pharma industry.

As the global healthcare landscape evolves, India continues to strengthen its position as the pharmacy of the world. During this week of celebrating patient safety, Matruprasad P.riyadarshi shares insight on how the Indian pharmaceutical industry has been transforming and is poised for tremendous growth. He emphasizes that with quality, innovation, and collaboration at its core, the Indian pharma industry is ready to meet global healthcare demands. US Pharmacopeia remains committed to supporting the industry through our rigorous standards and expertise, ensuring safe, effective, and quality medicines reach every patient. Together, we can ensure that India remains a leader in global healthcare while safeguarding patient health. 📹 Watch for more insights and share !